Business
AorTech Announces Year End Preliminary Results
AorTech Announces Year End Preliminary Results.
About this update from Rua Life Sciences Plc
[{"type":"text","content":"\n \nRNS Number : 4412L Aortech International PLC 01 August 2011 \n \n\nAorTech International plc\n(\"the Company\" or \"the Group\")\n \nPreliminary Results for the year ended 31 March 2011\n \n \nAorTech International plc (AIM: AOR), the biomaterials and medical device development company, today announces its preliminary results for the year ended 31 March 2011.\n \nHighlights (vs. prior year)\n· Group turnover increased from £1.4m to £1.6m\n· Pre-tax loss increased from £1.9m to £2.5m\n· Cash reserves decreased from £2.9m to £1.4m\n· Research and manufacturing consolidation in the USA\n· Strong commercial progress\n \n \n- Ends - \n \n \nFor further information contact:\n \nAorTech International plc \nFrank Maguire, Chief Executive Tel: + 1 801 201 4336 \n \nAorTech International plc \nSarah Price, Media Relations Tel: + 1 801 550 4349 \ne-mail [email protected]\n \nEvolution Securities Limited\nBobbie Hilliam / Chris Clarke Tel: +44 20 7071 4300 \n\n \n \n \nNote to Editors:\n \nAbout AorTech International plc\n \nListed on AIM in London, AorTech International Plc wholly owns AorTech Biomaterials in Melbourne, Australia and AorTech Medical Devices in Salt Lake City, UT, USA. AorTech Biomaterials was formed in July 1997 to develop and commercialise Elast-Eon™, a highly useful and b...